SEP 06, 2018 11:00 PM PDT

First FDA Approved Drug Derived From Marijuana Used to Treat Two Rare Forms of Epilepsy

WRITTEN BY: Amanda Kahl

The FDA (Food and Drug Administration) approved the first oral cannabidiol solution called Epidiolex in June of 2018. This medicine was approved as a treatment for two forms of severe drug-resistant epilepsy. This is the first time that the federal government has approved a medication derived directly from the cannabis plant. 

LGS (Lennox-Gastaut Syndrome) and DS (Dravet Syndrome) are two rare and severe forms of epilepsy with onset in early childhood. "The syndromes are categorized as developmental and epileptic encephalopathies, in which the epileptic activity is thought to contribute to developmental delay and behavioral abnormalities beyond the pathology of the underlying disease," stated Teresa Buracchio, who is the Clinical Team Leader from the Division of Neurology Products at the FDA. These forms of refractory epilepsy syndromes are resistant to drugs that are typically used for the treatment of seizures. Buracchio further explains that "Both syndromes are associated with higher rates of mortality than in the general epilepsy population, primarily due to status epilepticus and sudden unexpected death in epilepsy patients." 

The FDA conducted three randomized, double-blind, placebo-controlled trials with patients who have LGS and DS. The results from the study performed with 225 patients with LGS showed significant improvement with the use of CBD, "The median number of "drop seizures" (which can cause falls) during a 28-day period fell from 85.5 to 44.9 in the high-dose group (a decrease of 49 percent), from 86.9 to 50 in the low-dose group (43 percent), and from 80.3 to 72.7 in the placebo group (21 percent)." In the study that was performed with 120 patients with DS also showed significant improvement with the use of CBD, "The median number of convulsive seizures over 28 days fell from 12.4 to 5.9 in the CBD group (a drop of 52 percent) and from 14.9 to 14.1 in the placebo group (5 percent)."

Epidiolex contains CBD, which is a cannabinoid found within the marijuana plant. It is known that cannabinoids interact with a multitude of neurotransmitters and neuromodulator systems and have the ability to interact with cellular pathways. By acting as ligands, they are able to modulate a receptor's behavior and their downstream biological pathways. According to GW Pharmaceuticals (the company that created the drug), CBD produces an anticonvulsant effect, it does this by, "...modulating a number of endogenous systems including, but not limited to neuronal inhibition (synaptic and extrasynaptic GABA channels, modulation of intracellular calcium (TRPV, VDAC, GPR55), and possible anti-inflammatory effects."

Both forms of seizures are difficult to control and with the treatment option of CBD for patients diagnosed it can dramatically improve their quality of life. The use of medical marijuana is approved in 30 states and Washington D.C., 25 out of these 30 states specifically recognize epilepsy as a qualifying condition. These states allow treatment of epilepsy with low dose THC or high dose CBD oil and are now making it easier to legally obtain the drug Epidiolex. The creation of this drug and its approval are a huge step in offering patients a safe, controlled, and tested medication. 

Sources: ReasonFDA Briefing DocumentGWPharm Mechanism of Action

About the Author
  • Amanda has a Bachelor's in Biological Sciences from the University of Cincinnati. She has a passion for animals, conservation, and environmental sciences. Through her career in science and research, she is able to develop her passion and hopes to pass on to others the joy of learning about science.
You May Also Like
SEP 19, 2019
Cannabis Sciences
SEP 19, 2019
The Science Behind Hemp
With the signing of the latest farm bill, President Trump has just legalized the cultivation of hemp. The idea behind this legislation was to boost agricul...
SEP 19, 2019
Cannabis Sciences
SEP 19, 2019
Surprising Study Finds that Pot May Increase Sperm Concentrations
In a surprising report published in the journal Human Reproduction scientists from Harvard reveal their results of smoking marijuana on sperm count. A...
SEP 19, 2019
Cannabis Sciences
SEP 19, 2019
Guess What? Marijuana Really Does Cause the "Munchies"!
Before you say "duh", take a moment to put yourself in a scientist's shoes. In modern scientific parlance, the phrase "data or it didn&#...
SEP 19, 2019
Health & Medicine
SEP 19, 2019
The University of Maryland to Launch a Graduate Degree in Cannabis
The University of Maryland plans to be the first university in the United States to offer a Master of Science (MS) in Medical Cannabis Science and Therapeu...
SEP 19, 2019
Cannabis Sciences
SEP 19, 2019
New Cannabis Research: UC Davis Teams up With Biopharmaceutical Research Company and DEA
While cannabis laws move forward, research to back them up lags behind. A new multi-sector research endeavor will aim to bring cannabis sciences more up-to...
SEP 19, 2019
Cannabis Sciences
SEP 19, 2019
Cannabis Buds for Mid-Level Pain Relief
A study called, "The Effectiveness of Self-Directed Medical Cannabis Treatment for Pain," published in the journal Complementary Therapies in Med...
Loading Comments...